Article Text
EBM opinion and debate
Improving FDA postmarket adverse event reporting for medical devices
Statistics from Altmetric.com
Footnotes
Twitter @ftbourgeois
Contributors All authors contributed to the drafting and critical revision of the manuscript, and have approved submission of this final version.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.